NPİSTANBUL Nöropsikiyatri Hastanesi'nin ve uzmanlarının katkılarıyla yapılan volümetri çalışmasına ait tam metin çalışmasını İngilizce olarak indirebilirsiniz.
Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson’s disease: Contribution of automated segmentation neuroimaging method
Basar Bilgic, Ali Bayram, Ali Bilgin Arslan, Hasmet Hanagasi, Burcu Dursun, Hakan Gurvit,
Murat Emre , Ebba Lohmann
Background: Parkin (PARK2) gene mutations are the predominant cause of autosomal recessive parkinsonism.
Characteristic features include: early onset symptoms with slow clinical course, good response to
low doses of levodopa, and frequently treatment-induced dyskinesia. Studies using a voxel-based
morphometry approach showed a decrease in the gray matter volume of the basal ganglia in mutation
carriers during the symptomatic stages. A bilateral, presumably compensatory increase of basal
ganglia gray matter value was recently demonstrated in asymptomatic Parkin mutation carriers.
Behavioral disorders including: anxiety, psychosis, panic attacks, depression, disturbed sexual, behavioral
and obsessiveecompulsive disorders have been reported in these patients.
Method: A total of 28 Parkinson’s Disease (PD) patients consisting of 10 Young-Onset without Parkin
mutations (YOPD), 9 Young-Onset with Parkin mutations (YOPD-p), 9 Late-Onset without Parkin
mutations (LOPD) and 32 healthy control subjects were studied with an automated volumetric assessment
method to quantify subcortical atrophy. Patients but not controls also underwent a neuropsychological
and neuropsychiatric assessment.
Results: Results revealed a reduction of bilateral caudate nuclei volumes in YOPD-p patients compared to
the YOPD patients while there were no statistically significant differences between other groups. YOPD-p
patients showed similar results to other patient groups on neuropsychiatric and neuropsychological
Conclusion: YOPD-p and YOPD patients showed a different pattern of volume changes in basal ganglia.
Despite its relatively benign clinical course, carrying the Parkin mutation seems to be associated with
greater atrophy in subcortical structures. Failure of compensatory mechanisms, different mutation types
and pathophysiologic processes may underlie this diverse pattern of subcortical brain changes.
click here to download full article